Women's Health Innovation Summit 2022

Women's Health Innovation Summit

Accelerating innovation, investment, research and partnerships, to improve the access and quality of healthcare for women worldwide.

Download 2022 Agenda
The Westin Copley, Boston USA
29-30 September, 2022

3 Opportunities, 1 Application. Apply for our Innovation Showcase, CEO Forum and The Ferring Innovation Council...

WHIS 2022 ADVISORY BOARD


WHY ATTEND?

Now in its fourth year, we’re delighted to be reconvening face-to-face in Boston this September for our biggest industry-leading networking event to date.

Our past annual summits’ have succeeded in addressing and bringing awareness to a wide range of verticals, challenges and unmet needs for women and their health. Building on this, we will be expanding the scope to consider what’s next in accelerating innovation, investment, research, and partnerships to continue to improve the access of quality of care for women worldwide.

Industry Inflection Point: Our mission for 2022 and beyond is to draw upon the lessons learnt and consider how to continue to drive momentum in an industry that’s gone from being considered ‘niche to essential’. We want to bring together more stakeholders, include more unmissable networking opportunities and introduce a tailored two- tracked learning experience.

Our 2022 agenda is now live and can be downloaded here.

 

 

3 OPPORTUNITIES, 1 APPLICATION

EXPANDED INNOVATION SHOWCASE

For three years, the Women’s Health Innovation Spotlight has provided startups with a unique and interesting technologies, services, and products the opportunity to present in front of our audience of investors and industry leaders.

This year, we’re increasing the number of finalists. Our esteemed Selection Committee will choose 24 emerging companies to take to the stage to present their vision of the future of the women’s health industry.

Spread across both days of the summit, the showcase will be split into two categories: early-stage funding on day one and later-stage funding on day two, enhancing visibility for startups competing against similarly positioned peers.

All applications are stage agnostic and can relate to any solutions within women’s health, from ovarian cancer to fertility. Applications close Friday 5th August.

CEO & FOUNDERS FORUM

Come together with like-minded leaders in women’s health to learn, network, and grow. The CEO & Founders Forum is an application-only event and we will inform you if you are accepted to join.

THE FERRING INNOVATION COUNCIL

A premium opportunity for innovators and startups in reproductive medicine and women’s health.

Are you focused on meeting an unmet need in reproductive medicine or women’s health? Do you have an idea to improve the family building journey, improve access or outcomes? Ferring wants to hear from you.

Ferring is committed to be the world-leading, most trusted healthcare company in reproductive medicine and maternal health by ensuring a robust and growing development pipeline and selectively investing and partnering with innovators.

If selected for the Ferring Innovation Council, you will have the opportunity to present and discuss your innovation in a closed-door session with Ferring R&D scientists, medical experts, commercial experts and business development professionals. Later, you will be invited to network with others committed to addressing unmet needs in reproductive medicine and women’s health.

APPLICATIONS NOW CLOSED

WHIS SELECTION COMMITtEE

FERRING SELECTION COMMITTEE

POSTER PRESENTATION

New for 2022! Are you currently undergoing research that focuses on Women's Health? This is your opportunity to present your research in front of pharmaceutical and biotech organisations, as well as fellow academics.

Submit your abstract using our form below and we will be in touch once your abstract has been reviewed. If successful, your Poster will be presented in front of over 400 attendees.

Please note, if you application is successful, one author of the Poster must be available on 29-30 September and book their place with our academic rate.

APPLY NOW

Abstract Submission Guidelines

  • May be only submitted for poster presentations.
  • Abstracts must be submitted via the online submission site only. Abstracts submitted by email or fax will not be accepted.
  • Abstracts must be received by 31 August 2022. Abstracts received after the deadline will not be considered.
  • One Poster Author must be available and register for the Summit (29-30 September).
  • Abstracts must be submitted in English.
  • No changes will be made to submitted and accepted abstracts.

2022 Partners

Headline Partner

Knowledge Partner

Platinum Partners

Gold Partners

Event Partners

Event & Media Partner

Media Partner

2022 Speakers

 

Valerie Palmieri

Executive Chairwoman
Aspira Women's Health

Valerie Palmieri

Executive Chairwoman
Aspira Women's Health

Valerie Palmieri

Executive Chairwoman
Aspira Women's Health
 

Kate Ryder

Founder & CEO
Maven Clinic

Kate Ryder is the founder and CEO of Maven, the largest virtual clinic for women’s and family health. Maven offers virtual care and services across fertility, maternity, and pediatrics, and operates the largest women's and family health telehealth network globally. With Maven, employers and health plans can see improved maternal outcomes, lower costs, and attract and retain more parents in the workforce.

Kate Ryder

Founder & CEO
Maven Clinic

Kate Ryder

Founder & CEO
Maven Clinic

Kate Ryder is the founder and CEO of Maven, the largest virtual clinic for women’s and family health. Maven offers virtual care and services across fertility, maternity, and pediatrics, and operates the largest women's and family health telehealth network globally. With Maven, employers and health plans can see improved maternal outcomes, lower costs, and attract and retain more parents in the workforce. Named #1 Most Innovative Healthcare Company by Fast Company in 2020, Maven has raised more than $200 million in capital from top investors, including Sequoia Capital, Oak HC/FT, Dragoneer Investment Group, and Lux Capital.

Kate founded Maven in 2014, reimagining healthcare for women and families from the ground up after seeing first hand how the lack of access to care impacted those starting a family and returning to work as new parents. Prior to founding Maven, Kate worked in venture capital and as a journalist, writing for The Economist from Southeast Asia, New York and London and for The New Yorker. In 2009, she worked with former U.S. Treasury Secretary Hank Paulson, helping him write his memoirs about the financial crisis.

Kate has been named to Fortune’s 40 Under 40 and to Fast Company’s “Most Creative People.” She has spoken on stage at industry events including the Forbes Healthcare Summit, Fortune Brainstorm Health, the Oliver Wyman Health Innovation Summit and HLTH. Kate received her B.A. from the University of Michigan and her MSc from the London School of Economics. She lives in Brooklyn, New York with her husband and three children.

 

Kalahn Taylor-Clark, PhD MPH

Vice President, Strategic Partnerships and Innovation
Myovant

Kalahn Taylor-Clark, PhD MPH

Vice President, Strategic Partnerships and Innovation
Myovant

Kalahn Taylor-Clark, PhD MPH

Vice President, Strategic Partnerships and Innovation
Myovant
 

Marsha Henderson

Former Associate Commissioner Women's Health
FDA

Marsha Henderson

Former Associate Commissioner Women's Health
FDA

Marsha Henderson

Former Associate Commissioner Women's Health
FDA
 

Bipin Dalmia

Vice President - Strategy, Business Development, and New Product Planning
Ferring Pharmaceuticals U.S.

Bipin Dalmia

Vice President - Strategy, Business Development, and New Product Planning
Ferring Pharmaceuticals U.S.

Bipin Dalmia

Vice President - Strategy, Business Development, and New Product Planning
Ferring Pharmaceuticals U.S.
 

Lucy Perez, PhD

Senior Partner
McKinsey & Company

Lucy is a Senior Partner in McKinsey’s Boston office. Lucy has 15+ years of experience advising CEOs and top teams at leading pharma, biotech and life sciences companies globally on growth strategy, innovation, sustainability, and organizational transformation.

Lucy co-leads McKinsey’s ESG domain and McKinsey’s All-In DEI efforts in North America.  She also sponsors the Hispanic Latino Network at McKinsey and leads our research efforts on health equity.

Lucy Perez, PhD

Senior Partner
McKinsey & Company

Lucy Perez, PhD

Senior Partner
McKinsey & Company

Lucy is a Senior Partner in McKinsey’s Boston office. Lucy has 15+ years of experience advising CEOs and top teams at leading pharma, biotech and life sciences companies globally on growth strategy, innovation, sustainability, and organizational transformation.

Lucy co-leads McKinsey’s ESG domain and McKinsey’s All-In DEI efforts in North America.  She also sponsors the Hispanic Latino Network at McKinsey and leads our research efforts on health equity.

Lucy works extensively with number of biopharma and life science clients on broad range of topics, with recent focus on ESG/ sustainability, evidence generation, and digital/analytics programs to improve patient outcomes and support sustainable, inclusive growth.

Led efforts for a leading biopharma to define their ESG strategy, partnership strategy, and stakeholder engagement approach

Led efforts for a leading biopharma to embed health equity as a core principle in their R&D priorities and ways of working across the value chain

Led efforts to assess internal and external portfolio productivity and pricing models to optimize the R&D strategy and redesign the organization for a top pharmaceutical company

Led efforts for a leading biopharma to transform how it engages with customers through digital transformation, applying advanced analytics and embedding agile ways of working across their six largest markets that delivered $300M+ of near-term growth

Sponsor of McKinsey’s Early Stage Investor Conference, an annual event convening 200+ entrepreneurs and 1000+ investors interested in bio/med/health tech and sustainability innovation

Before joining McKinsey, Lucy was a research fellow at Memorial Sloan-Kettering Cancer Center, where she was involved in the development of novel treatments for solid tumors. She was also a Howard Hughes Medical Institute research fellow at Harvard University while completing her doctoral studies. She is co-inventor on multiple patents and has published in peer-reviewed journals.

 

Jill Angelo

CEO and Founder
Gennev

Jill is the co-founder and CEO of Gennev whose mission is to empower every woman to improve her quality of life through menopause by creating a higher standard of care for post-reproductive healthcare.

Jill has 20 years’ experience in the tech industry, primarily at Microsoft in executive roles such as Chief of Staff to the CMO, Director of Global Media, and Product Management for Emerging Markets. Jill is also a member of the Board of Directors for Special Olympics of Washington.

Jill Angelo

CEO and Founder
Gennev

Jill Angelo

CEO and Founder
Gennev

Jill is the co-founder and CEO of Gennev whose mission is to empower every woman to improve her quality of life through menopause by creating a higher standard of care for post-reproductive healthcare.

Jill has 20 years’ experience in the tech industry, primarily at Microsoft in executive roles such as Chief of Staff to the CMO, Director of Global Media, and Product Management for Emerging Markets. Jill is also a member of the Board of Directors for Special Olympics of Washington.


Named as one of Inc. Magazine’s 2020 Top 100 Female Founders, Jill is a driving force for bringing effective health solutions to women in the most vibrant years of their lives.

 

Alyssa Jaffee

Partner
7wireVentures

Alyssa Jaffee

Partner
7wireVentures

Alyssa Jaffee

Partner
7wireVentures
 

Fahimeh Sasan

MD, Founding Physician & OBGYN, Chief Innovation Officer
Kindbody

Fahimeh Sasan

MD, Founding Physician & OBGYN, Chief Innovation Officer
Kindbody

Fahimeh Sasan

MD, Founding Physician & OBGYN, Chief Innovation Officer
Kindbody
 

Sandy Milligan

MD, JD, Head of R&D
Organon

Sandy Milligan

MD, JD, Head of R&D
Organon

Sandy Milligan

MD, JD, Head of R&D
Organon
 

Stephanie Faubion

MD, MBAm FACP, NCMP, IF, Medical Director, Physician and Director
The North American Menopause, Mayo Clinic Center for Women's Health

Dr. Faubion completed her undergraduate studies at the University of Texas at Austin and medical school and residency in internal medicine and pediatrics at the University of Texas Health Science Center at Houston. She received her Master of Business Administration at the Carlson School of Management at the University of Minnesota in 2019.

Stephanie Faubion

MD, MBAm FACP, NCMP, IF, Medical Director, Physician and Director
The North American Menopause, Mayo Clinic Center for Women's Health

Stephanie Faubion

MD, MBAm FACP, NCMP, IF, Medical Director, Physician and Director
The North American Menopause, Mayo Clinic Center for Women's Health

Dr. Faubion completed her undergraduate studies at the University of Texas at Austin and medical school and residency in internal medicine and pediatrics at the University of Texas Health Science Center at Houston. She received her Master of Business Administration at the Carlson School of Management at the University of Minnesota in 2019.
She is Professor and Chair of the Department of Medicine at Mayo Clinic in Jacksonville, Florida and the Penny and Bill George Director of the Center for Women’s Health. In 2019 she was named Medical Director of The North American Menopause Society.
Her clinical research interests include menopause and sexual health in women. She is Principal Investigator for the Data Registry on Experiences of Aging, Menopause and Sexuality (DREAMS). She has served on the board of trustees for the North American Menopause Society and the board of directors for the International Society for the Study of Women’s Sexual Health. She also serves as editor of the journal, Menopause, and is on the editorial board of Journal of Sexual Medicine.

 

Tania Small

MD, Vice President, Global Medical Affairs Oncology Head
GSK

Tania Small, MD is Global Medical Affairs Therapeutic Area Head of Oncology at GSK and Chair of the diversity, equity, and inclusion R&D Council. She has built and leads an organization of approximately 500 professionals focused on patient-driven science, breaking down the barriers to access and driving impactful and innovative solutions to improve the outcome of individuals with cancers. Dr. Small was trained in Hematology/Oncology and bone marrow transplant at Columbia University, New York Presbyterian where she also completed a genetic research fellowship.

Tania Small

MD, Vice President, Global Medical Affairs Oncology Head
GSK

Tania Small

MD, Vice President, Global Medical Affairs Oncology Head
GSK

Tania Small, MD is Global Medical Affairs Therapeutic Area Head of Oncology at GSK and Chair of the diversity, equity, and inclusion R&D Council. She has built and leads an organization of approximately 500 professionals focused on patient-driven science, breaking down the barriers to access and driving impactful and innovative solutions to improve the outcome of individuals with cancers. Dr. Small was trained in Hematology/Oncology and bone marrow transplant at Columbia University, New York Presbyterian where she also completed a genetic research fellowship. She subsequently continued her focused on both hematology and stem cell transplant. She has done research in oncology, hematology, gene therapy and stem cell transplantation, and received grants from the U.S. National Institutes of Health (NIH) for her translational research in gene therapy and regenerative medicine. In previous roles with Novartis Oncology and Ipsen, Dr. Small successfully led the launch programs of multiple oncology therapies while overseeing both clinical development programs as well as medical affairs programs. She has also led many patient-centered and diversity initiatives in previous roles, working closely with the U.S. FDA, Congress and the American Society of Clinical Oncology (ASCO) to improve the diversity enrollment into oncology clinical trials and elderly programs. She is passionate about creating a world class oncology program that will successfully deliver the transformational medicines needed to revolutionize the experience and outcomes of patients.

 

Emma Kemble

Engagement Manager
McKinsey & Company
​Emma Kemble is an engagement manager with McKinsey’s Pharmaceutical and Medical Products practice. She leads the firm’s research on FemTech and serves clients across the healthcare value chain (Pharma, Biotech, PBM, Payer, Pharmacy).

Emma Kemble

Engagement Manager
McKinsey & Company

Emma Kemble

Engagement Manager
McKinsey & Company
​Emma Kemble is an engagement manager with McKinsey’s Pharmaceutical and Medical Products practice. She leads the firm’s research on FemTech and serves clients across the healthcare value chain (Pharma, Biotech, PBM, Payer, Pharmacy). Emma has expertise in women’s health, market access, pricing, and pharmacy benefit management.
​Helped contraceptive provider to shape global go-to-market strategy

Prepared gyn oncology client for future value and market access hurdles and advised on incorporating value and access in both clinical and business development

Developed strategy and identified the next wave of growth for a pharmacy benefit manager

Assessed key trends in pharmaceutical pricing and access in the US and determined implications for client

​Emma earned a B.A. in Economics from Georgetown University. She took a sabbatical from McKinsey to join a healthcare venture in Bangladesh, aimed at developed a network of family and women’s health clinics in Bangladesh.
 

Elizabeth Garner

Chief Scientific Officer
Ferring Pharmaceuticals U.S.

Elizabeth Garner is Chief Medical Officer at ObsEva, a Swiss women’s health specialty pharmaceutical company headquartered in Geneva. With over a decade of experience in the pharmaceutical industry, Dr. Garner has wide expertise in drug development, including clinical trial design and conduct, regulatory and FDA Advisory Committee strategy, support of commercial launch planning, medical affairs, and pharmacovigilance.

Elizabeth Garner

Chief Scientific Officer
Ferring Pharmaceuticals U.S.

Elizabeth Garner

Chief Scientific Officer
Ferring Pharmaceuticals U.S.

Elizabeth Garner is Chief Medical Officer at ObsEva, a Swiss women’s health specialty pharmaceutical company headquartered in Geneva. With over a decade of experience in the pharmaceutical industry, Dr. Garner has wide expertise in drug development, including clinical trial design and conduct, regulatory and FDA Advisory Committee strategy, support of commercial launch planning, medical affairs, and pharmacovigilance. As a member of ObsEva’s Executive Committee, she provides strategic leadership on the Company’s overall development strategy and frequently represents ObsEva to investor, Key Opinion Leader (KOL), and other key stakeholders.
From 2014 to 2019, Dr. Garner was Chief Medical Officer of Agile Therapeutics, located in Princeton, NJ. She played a crucial role during Agile’s 2014 Initial Public Offering and was instrumental in the Company’s Investor Relations, Communications, and Business Development strategies. Dr. Garner led the clinical development of Twirla®, Agile’s low-dose contraceptive patch, took the Company through an FDA dispute resolution process, and was the presenter and moderator for Agile’s successful FDA Advisory Committee meeting in October 2019, which led to FDA approval of Twirla® in February, 2020. She also led pre-launch activities, including commercial support, medical affairs, KOL development, and the pharmacovigilance and Medical Information programs.
Prior to her position at Agile, Dr. Garner was Vice President of Medical Affairs, Preventive Care at Myriad Genetics, where she managed the women’s health research, publication, and KOL development programs, provided medical and scientific input on Myriad’s marketing and new product strategies, served as its media spokesperson, and directed an experienced team of Field Medical Specialists. Before that, she was Senior Director at Abbott Laboratories, where she oversaw all clinical aspects of the global Phase 3 endometriosis development program for elagolix, which was FDA-approved in 2018.
From 2007 to 2011, Dr. Garner was Associate Director then Director of Clinical Research at Merck Research Laboratories. As a leader on the human papillomavirus (HPV) vaccine program she was instrumental in achieving successful outcomes on important regulatory submissions. Dr. Garner also served as chair of the Gardasil®9 HPV vaccine program Product Development Team, leading scientific, regulatory, global access and medical affairs strategies. Dr. Garner was the presenter and moderator for the successful 2010 FDA Gardasil® Advisory Committee Meeting. She also had substantial involvement in commercialization strategy and KOL development, and participated in due diligence on infectious disease and women’s health products.
Dr. Garner received joint M.D. and M.P.H degrees from Harvard Medical School and Harvard School of Public Health. She was trained in obstetrics and gynecology at Brigham and Women’s/Massachusetts General Hospitals and completed a fellowship in gynecologic oncology at Brigham and Women’s/Dana Farber Cancer Institute. Prior to entering the pharmaceutical industry, Dr. Garner focused on academic clinical practice, basic science research in ovarian cancer, and teaching and mentorship of fellows, residents, and medical students at Harvard Medical School. She is an author on numerous peer-reviewed scientific papers.
Dr. Garner is a member of the Board of Directors of Kezar Life Sciences, a publicly traded company focused on the development of new therapies targeting protein homeostasis for the treatment of autoimmune diseases and cancer. She serves on the board’s audit and clinical strategy & execution committees. She is also on the Board of Directors of the Drug Information Association (DIA), a member-driven volunteer organization for global healthcare product development; she serves on the audit committee. She is on the Board of Directors and is Chair of the finance committee of the American Medical Women’s Association, a professional organization which functions at the local, national, and international level to advance women in medicine. Dr. Garner also serves on the Board of the Executive Women of New Jersey and was a 2018 honoree at its Salute to the Policy Makers gala, which recognizes executive women leaders across all industries. She is also on the Board of CorStone, a global non-profit organization focused on resilience in youth. Dr. Garner was a 2019 awardee of the PharmaVoice 100 Most Inspiring Individuals in the life sciences industry.

 

Elizabeth Bailey

Managing Director
Rhia Ventures

Elizabeth Bailey

Managing Director
Rhia Ventures

Elizabeth Bailey

Managing Director
Rhia Ventures
 

Kelle Moley, MD

Deputy Director of Reproductive Health Technologies Global Health, Discovery and Translational Sciences
Bill & Melinda Gates Foundation

Dr. Kelle Moley is a career physician-scientist obstetrician/gynecologist who currently leads the Reproductive Health Technologies Domain within the Discovery & Translational Sciences, Global Health Division at the Bill and Melinda Gates Foundation.

Kelle Moley, MD

Deputy Director of Reproductive Health Technologies Global Health, Discovery and Translational Sciences
Bill & Melinda Gates Foundation

Kelle Moley, MD

Deputy Director of Reproductive Health Technologies Global Health, Discovery and Translational Sciences
Bill & Melinda Gates Foundation

Dr. Kelle Moley is a career physician-scientist obstetrician/gynecologist who currently leads the Reproductive Health Technologies Domain within the Discovery & Translational Sciences, Global Health Division at the Bill and Melinda Gates Foundation.  Kelle joined BMGF in July 2020, with a 30-year history of basic and translational research on reproductive health issues in females throughout the life course-- from organismal to cellular and molecular levels of metabolic, developmental biology, embryo implantation and decidualization, and infectious diseases of the female reproductive tract.

 

Kelle earned her BA from Wellesley College, and her MD from Yale Medical School. Thereafter, she pursued an Obstetrics & Gynecology Residency and a Fellowship in Reproductive Endocrinology & Fertility at Washington University in St. Louis School of Medicine. Kelle then spent the next 3 decades of a thriving research career at Washington University—rising to become the James P. Crane Professor of Obstetrics & Gynecology, Vice Chair of Obstetrics & Gynecology, Chief of the Division of Basic & Translational Research for the Department of Obstetrics & Gynecology, Co-Director of the Institute of Clinical & Translational Science for the School of Medicine, and Director of the Center for Reproductive Health Sciences at the School of Medicine. Her research (published in some 150 peer-reviewed primary articles) led to an international reputation along with numerous honors, including election to the National Academy of Medicine in 2014. She also earned a reputation as a superb mentor to trainees, leading the reproductive endocrinology fellowship program at Washington University until she left academia in 2018. After a 2-year stint as Chief Scientific Officer and Senior Vice President of the March of Dimes she left to pursue her new position at BMGF.

 

Jamie White

Health Science Strategy and Relations Lead in the Office of Research on Women’s Health (ORWH)
National Institutes of Health (NIH)

Jamie White

Health Science Strategy and Relations Lead in the Office of Research on Women’s Health (ORWH)
National Institutes of Health (NIH)

Jamie White

Health Science Strategy and Relations Lead in the Office of Research on Women’s Health (ORWH)
National Institutes of Health (NIH)
 

Tammeka Evans

Global Public Health and Innovation, Senior Director
Viiv Healthcare

As Senior Director of Global Public Health and Innovation at ViiV Healthcare, a subsidiary of GlaxoSmithKline, solely focused on HIV, Tammeka Evans is a consummate public health leader. Her passion to address and eliminate health disparities and inequities that impact women across the globe has been focused on HIV which disproportionately affects communities of color and low-and-middle income countries. Along with her expertise in both disparities elimination and implementation science research, she is a strong advocate for implementing innovative approaches to increase access to HIV biomed

Tammeka Evans

Global Public Health and Innovation, Senior Director
Viiv Healthcare

Tammeka Evans

Global Public Health and Innovation, Senior Director
Viiv Healthcare

As Senior Director of Global Public Health and Innovation at ViiV Healthcare, a subsidiary of GlaxoSmithKline, solely focused on HIV, Tammeka Evans is a consummate public health leader. Her passion to address and eliminate health disparities and inequities that impact women across the globe has been focused on HIV which disproportionately affects communities of color and low-and-middle income countries. Along with her expertise in both disparities elimination and implementation science research, she is a strong advocate for implementing innovative approaches to increase access to HIV biomedical prevention options. She actively leads efforts in research and development to increase the representation of women and racial and ethnic minorities in clinical trials. 

 

 

Jackie Rotman

Founder
Center of Intimacy Justice

Jackie Rotman

Founder
Center of Intimacy Justice

Jackie Rotman

Founder
Center of Intimacy Justice
 

Donna Parr

Managing Partner
Cross-Border Impact Ventures

Donna Parr

Managing Partner
Cross-Border Impact Ventures

Donna Parr

Managing Partner
Cross-Border Impact Ventures
 

Julie Stone

Managing Director of Health & Benefits
WTW

Julie Stone

Managing Director of Health & Benefits
WTW

Julie Stone

Managing Director of Health & Benefits
WTW
 

Todd Albin

Chief Executive Officer
Cedar Health Research powered by Aspen Insights

Todd Albin is a founding member of Cedar Health Research and an expert in the areas of clinical research site operations and patient engagement with more than two decades of experience as an accomplished leader in the clinical research industry. His past experience includes management roles with Synexus, PPD/Acurian, and Ora where he led global teams supporting operations, investigator site relations, and patient recruitment and retention.

Todd Albin

Chief Executive Officer
Cedar Health Research powered by Aspen Insights

Todd Albin

Chief Executive Officer
Cedar Health Research powered by Aspen Insights

Todd Albin is a founding member of Cedar Health Research and an expert in the areas of clinical research site operations and patient engagement with more than two decades of experience as an accomplished leader in the clinical research industry. His past experience includes management roles with Synexus, PPD/Acurian, and Ora where he led global teams supporting operations, investigator site relations, and patient recruitment and retention.

 

Marshika Keith-Vickers

Senior Program Director, Women's Health
Premier Research

Marshika Keith-Vickers is an experienced clinical operations leader and brings more than 15 years of experience spanning Phase 1-4, registry, and late phase clinical trials for multiple therapeutic indications, specializing in Women’s Health, Oncology and CNS. Keith-Vickers’ extensive experience includes providing leadership and management of global teams for large and mid-size CROs.

 

In her current role, Keith-Vickers is committed to providing strategic and operational leadership to ensure high-quality performance and delivery.

 

Marshika Keith-Vickers

Senior Program Director, Women's Health
Premier Research

Marshika Keith-Vickers

Senior Program Director, Women's Health
Premier Research

Marshika Keith-Vickers is an experienced clinical operations leader and brings more than 15 years of experience spanning Phase 1-4, registry, and late phase clinical trials for multiple therapeutic indications, specializing in Women’s Health, Oncology and CNS. Keith-Vickers’ extensive experience includes providing leadership and management of global teams for large and mid-size CROs.

 

In her current role, Keith-Vickers is committed to providing strategic and operational leadership to ensure high-quality performance and delivery.

 

Keith-Vickers holds a Bachelor of Science in Chemistry from Shaw University and a Master of Science in Biochemistry, with a concentration in Pharmacology and Physiology from North Carolina Central University.

 

Rachel Braun Scherl

Managing Partner, Co-Founder, & Chief Vagipreneur ®
SPARK Solutions for Growth

Rachel Braun Scherl

Managing Partner, Co-Founder, & Chief Vagipreneur ®
SPARK Solutions for Growth

Rachel Braun Scherl

Managing Partner, Co-Founder, & Chief Vagipreneur ®
SPARK Solutions for Growth
 

Delphine O'Rouke

Partner - Women's Health & Wellness
Goodwin Law

Delphine O'Rouke

Partner - Women's Health & Wellness
Goodwin Law

Delphine O'Rouke

Partner - Women's Health & Wellness
Goodwin Law
 

Ann Garnier

Founder & CEO
Lisa Health

Ann Garnier

Founder & CEO
Lisa Health

Ann Garnier

Founder & CEO
Lisa Health
 

Elizabeth Cherot

MD, Chief Medical Officer
Axia Women's Health

Dr. Elizabeth Cherot is Chief Medical Officer with Axia Women’s Health, a rapidly growing network of progressive, connected, and caring women’s health professionals with more 400 providers and nearly 200 locations across five states. She is an established and highly skilled physician with over 20 years of experience in obstetrics and gynecology.  In addition to her expert clinical skills, she is committed to improving OB/GYN care, reducing morbidity and mortality while implementing cost reduction and providing an efficient business model for today’s OB/GYN practice.

Elizabeth Cherot

MD, Chief Medical Officer
Axia Women's Health

Elizabeth Cherot

MD, Chief Medical Officer
Axia Women's Health

Dr. Elizabeth Cherot is Chief Medical Officer with Axia Women’s Health, a rapidly growing network of progressive, connected, and caring women’s health professionals with more 400 providers and nearly 200 locations across five states. She is an established and highly skilled physician with over 20 years of experience in obstetrics and gynecology.  In addition to her expert clinical skills, she is committed to improving OB/GYN care, reducing morbidity and mortality while implementing cost reduction and providing an efficient business model for today’s OB/GYN practice.

 

Dr. Cherot has been awarded numerous honors throughout her career including several National Excellence in Teaching Awards. She has also helped to pioneer the Enhanced Recovery after Surgery program in the United States, contributing to a significant reduction of opioid using in post-partum women.

 

In addition to being an accomplished clinician, Dr. Cherot holds an Executive MBA from Johns Hopkins University Carey School of Business. She resides in Central New Jersey with her husband and two children. 

 

Casey Santiago Albert

Managing Partner
SteelSky

Casey Santiago Albert

Managing Partner
SteelSky

Casey Santiago Albert

Managing Partner
SteelSky
 

Mary E. Flemming

MD, MPHD, FACOG, Co-Founder and Senior Clinical Advisor
Cayaba Care

Mary E. Fleming, MD, MPH, FACOG, an experienced OBGYN, is the co-founder and Senior Clinical Advisor at healthtech startup Cayaba Care. She provides direct clinical care as a locums physician across the country, and has strengthened her practice by serving as a medical legal consultant, physician editor, and president of the non-profit, Reede Scholars, Inc. Dr.

Mary E. Flemming

MD, MPHD, FACOG, Co-Founder and Senior Clinical Advisor
Cayaba Care

Mary E. Flemming

MD, MPHD, FACOG, Co-Founder and Senior Clinical Advisor
Cayaba Care

Mary E. Fleming, MD, MPH, FACOG, an experienced OBGYN, is the co-founder and Senior Clinical Advisor at healthtech startup Cayaba Care. She provides direct clinical care as a locums physician across the country, and has strengthened her practice by serving as a medical legal consultant, physician editor, and president of the non-profit, Reede Scholars, Inc. Dr. Fleming completed her undergraduate degree at Xavier University of Louisiana, medical degree at Vanderbilt University School of Medicine, and her residency in Obstetrics and Gynecology at Meharry Medical College. Due to her interests in eradicating health inequities and improving healthcare for the underserved, she matriculated to Harvard Medical School as a Commonwealth Fellow in Minority Health Policy where she obtained a Master in Public Health from the Harvard T.H. Chan School of Public Health. 5. Headshot and logo: Both attached here.

 

Allison Watkins-Conti

CEO and Founder
Watkins-Conti

Allison Watkins-Conti

CEO and Founder
Watkins-Conti

Allison Watkins-Conti

CEO and Founder
Watkins-Conti
 

Ezekiel Fink

Chief Medical Officer, Principal Investigator of Neurology
Cedar Health Research powered by Aspen Insights

Ezekiel Fink M.D. is a Harvard trained physician with triple board certifications in neurology, pain medicine, and brain injury medicine. Dr. Fink joined Houston Methodist in 2014, designed and investigated numerous industry clinical trials, and was recognized for excellence in research by the Office of Research Protections in 2019. Today Dr.

Ezekiel Fink

Chief Medical Officer, Principal Investigator of Neurology
Cedar Health Research powered by Aspen Insights

Ezekiel Fink

Chief Medical Officer, Principal Investigator of Neurology
Cedar Health Research powered by Aspen Insights

Ezekiel Fink M.D. is a Harvard trained physician with triple board certifications in neurology, pain medicine, and brain injury medicine. Dr. Fink joined Houston Methodist in 2014, designed and investigated numerous industry clinical trials, and was recognized for excellence in research by the Office of Research Protections in 2019. Today Dr. Fink’s positions include being a key opinion leader in matters relating to opioids for the Centers for Disease Control and Prevention and the National Safety Council, an Assistant Clinical Professor at UCLA, and Medical Director of Pain for the Houston Methodist hospital system.

 

Linda Greub

General Partner
Avestria

Linda Greub

General Partner
Avestria

Linda Greub

General Partner
Avestria
 

Betsy Bluestone

Commercial Discovery Leader
P&G Ventures

Betsy Bluestone

Commercial Discovery Leader
P&G Ventures

Betsy Bluestone

Commercial Discovery Leader
P&G Ventures
 

Mylene Yao

Co-Founder & CEO
Univfy

Mylene Yao

Co-Founder & CEO
Univfy

Mylene Yao

Co-Founder & CEO
Univfy
 

Derek Sham

CEO and Founder
COSM Medical

Derek has 15+ years experience in medical devices R&D and commercialization in urology, gynecology, gastroenterology and cardiology. He is a General Manager with a successful PE-backed exit in urological diagnostics in 2016 and was inspired to launch Cosm as a result of his grandmother's health.

Derek Sham

CEO and Founder
COSM Medical

Derek Sham

CEO and Founder
COSM Medical

Derek has 15+ years experience in medical devices R&D and commercialization in urology, gynecology, gastroenterology and cardiology. He is a General Manager with a successful PE-backed exit in urological diagnostics in 2016 and was inspired to launch Cosm as a result of his grandmother's health.

 

Wei Escala

Founder and CEO
Eggschain

Wei Escala is the founder and CEO of Eggschain, a healthcare technology company built at the intersection of reproductive medicine, technology innovation, scientific research and humanity. A thought leader in the health tech, family building and cryogenic preservation industries, Ms. Escala holds the patent for the first blockchain-integrated inventory management and chain of custody technology for tracking bio specimens, including sperm, eggs, embryos, DNA, RNA, genome, stem cell, tissues and organs, and other genetic material.

Wei Escala

Founder and CEO
Eggschain

Wei Escala

Founder and CEO
Eggschain

Wei Escala is the founder and CEO of Eggschain, a healthcare technology company built at the intersection of reproductive medicine, technology innovation, scientific research and humanity. A thought leader in the health tech, family building and cryogenic preservation industries, Ms. Escala holds the patent for the first blockchain-integrated inventory management and chain of custody technology for tracking bio specimens, including sperm, eggs, embryos, DNA, RNA, genome, stem cell, tissues and organs, and other genetic material. As Eggschain CEO, she has built an all-star team of collaborators comprising technologists, business leaders, physicians and scientists, with a focus on continuing to develop game-changing innovation for patients, doctors, clinics and labs through the Eggschain platform.

A software engineer by training, Ms. Escala has built a career across the organizational spectrum, from Marketing and Brand Management to Software Leadership. Prior to Eggschain, Ms. Escala held executive roles at such Fortune 500 companies as Procter & Gamble, Frito Lay, Valvoline and Kraft Foods, where she managed P&Ls of up to 300 million USD. She is passionate about women’s health and the opportunity to enable security, transparency and peace of mind for people and families, enabling better decision making and helping advance humanity.

 

Karolynn Echols

MD, Director, Section FPMRS Associate Professor, Department of Obstetrics and Gynecology
Thomas Jefferson University

Karolynn Echols

MD, Director, Section FPMRS Associate Professor, Department of Obstetrics and Gynecology
Thomas Jefferson University

Karolynn Echols

MD, Director, Section FPMRS Associate Professor, Department of Obstetrics and Gynecology
Thomas Jefferson University
 

Carolee Lee

Founder & CEO
WHAM! (Women’s Health Access Matters)

Carolee Lee is an innovator, entrepreneur and thought leader dedicated to improving women’s health and wellbeing, and their opportunities to succeed. She was founder and CEO of Carolee Designs, one of the world’s leading accessories brands. Carolee launched WHAM (Women’s Health Access Matters), a nonprofit organization working to bring awareness and funding to women’s health research to transform women’s lives.

Carolee Lee

Founder & CEO
WHAM! (Women’s Health Access Matters)

Carolee Lee

Founder & CEO
WHAM! (Women’s Health Access Matters)

Carolee Lee is an innovator, entrepreneur and thought leader dedicated to improving women’s health and wellbeing, and their opportunities to succeed. She was founder and CEO of Carolee Designs, one of the world’s leading accessories brands. Carolee launched WHAM (Women’s Health Access Matters), a nonprofit organization working to bring awareness and funding to women’s health research to transform women’s lives. Carolee forged a research partnership with the RAND Corporation to create The WHAM Report, the first study to analyze the economic costs, benefits and social impacts of health research that focuses specifically on women. The WHAM Report is changing the conversation around women’s health research, proving women’s health research is an economic issue we cannot afford to ignore. Through partnerships with leading advocacy groups, business leaders, researchers and economists, WHAM is using this data drive change.

 

Carolee is also a mentor and leader in business, philanthropic and educational organizations. She is a past Chair and Foundation Board Chair of the Committee of 200, a community of the most successful women in business, and has served as director on the board of DSW, Inc. Carolee is a founding board member of The Breast Cancer Research Foundation, where she has served since 1986. She currently sits on the Women’s Leadership Board at The John F. Kennedy School of Government at Harvard University.

 

Nada Hanafi

Chief Strategy Officer
Experien Group

Nada Hanafi

Chief Strategy Officer
Experien Group

Nada Hanafi

Chief Strategy Officer
Experien Group
 

Kiki Freedman

Co-Founder and CEO
Hey Jane

Kiki Freedman

Co-Founder and CEO
Hey Jane

Kiki Freedman

Co-Founder and CEO
Hey Jane
 

Dana Northcraft

JD (she/her) Director of Innovation & Partnerships
EMAA Project

Dana Northcraft

JD (she/her) Director of Innovation & Partnerships
EMAA Project

Dana Northcraft

JD (she/her) Director of Innovation & Partnerships
EMAA Project
 

Rem Koning

MD, Assistant Professor
Harvard Business School

Rem Koning

MD, Assistant Professor
Harvard Business School

Rem Koning

MD, Assistant Professor
Harvard Business School
 

Crystal Tyler

PHD, MPH, Chief Health Officer
Rhia Ventures

Crystal Tyler

PHD, MPH, Chief Health Officer
Rhia Ventures

Crystal Tyler

PHD, MPH, Chief Health Officer
Rhia Ventures
 

Kate Marchio

Director, Women's Health
Sagentia Innovation

Kate Marchio

Director, Women's Health
Sagentia Innovation

Kate Marchio

Director, Women's Health
Sagentia Innovation
 

Katie Baker

Vice President Clinical Product & UK Medical Director
Femtec Health Inc

Katie Baker

Vice President Clinical Product & UK Medical Director
Femtec Health Inc

Katie Baker

Vice President Clinical Product & UK Medical Director
Femtec Health Inc
 

David Sable

Healthcare and Life Sciences Portfolio Manager
Special Situations Funds

David Sable

Healthcare and Life Sciences Portfolio Manager
Special Situations Funds

David Sable

Healthcare and Life Sciences Portfolio Manager
Special Situations Funds
 

Andrew Khair

Director, Strategy, Business Development and New Product Planning
Ferring Pharmaceuticals U.S.

Andrew Khair

Director, Strategy, Business Development and New Product Planning
Ferring Pharmaceuticals U.S.

Andrew Khair

Director, Strategy, Business Development and New Product Planning
Ferring Pharmaceuticals U.S.
 

Patrick Heiser

Associate Vice President, Clinical Development
Ferring Pharmaceuticals U.S.

Patrick Heiser

Associate Vice President, Clinical Development
Ferring Pharmaceuticals U.S.

Patrick Heiser

Associate Vice President, Clinical Development
Ferring Pharmaceuticals U.S.
 

Katie Barletta

Medical Director, Clinical Development
Ferring Pharmaceuticals U.S.

Katie Barletta

Medical Director, Clinical Development
Ferring Pharmaceuticals U.S.

Katie Barletta

Medical Director, Clinical Development
Ferring Pharmaceuticals U.S.
 

Aliëtte van der Wal

Business Leader - Consumer Health Business Development
Philips

Aliëtte van der Wal

Business Leader - Consumer Health Business Development
Philips

Aliëtte van der Wal

Business Leader - Consumer Health Business Development
Philips
 

Susan Nicholson

SVP Women's Health
Johnson & Johnson

Susan Nicholson

SVP Women's Health
Johnson & Johnson

Susan Nicholson

SVP Women's Health
Johnson & Johnson
 

Vrunda B Desai, MD

Medical Director
Cooper Surgical

Vrunda B Desai, MD

Medical Director
Cooper Surgical

Vrunda B Desai, MD

Medical Director
Cooper Surgical
 

Per Falk

President
Ferring Pharmaceuticals

Per Falk

President
Ferring Pharmaceuticals

Per Falk

President
Ferring Pharmaceuticals
 

Sari Kalin

Assistant Director, Health and Well-Being Strategy
Liberty Mutual Insurance

Sari Kalin

Assistant Director, Health and Well-Being Strategy
Liberty Mutual Insurance

Sari Kalin

Assistant Director, Health and Well-Being Strategy
Liberty Mutual Insurance
 

Danika Severino Wynn

VP of Abortion Access
Planned Parenthood

Danika Severino Wynn

VP of Abortion Access
Planned Parenthood

Danika Severino Wynn

VP of Abortion Access
Planned Parenthood
 

Sarah Jameson

Senior Associate
Aboretum Ventures

Sarah joined Arboretum in 2020 and is responsible for assessing potential investments and supporting Arboretum’s portfolio companies. Prior to joining Arboretum, Sarah spent eight years providing clinical and technical support for cardiac medical device procedures, sales, and clinical trials at Johnson & Johnson, Sorin, and, most recently, Boston Scientific.

 

Sarah earned an MSE in Biomedical Engineering and a BS in Cellular and Molecular Biology from the University of Michigan and an MBA from the Ross School of Business at the University of Michigan.

Sarah Jameson

Senior Associate
Aboretum Ventures

Sarah Jameson

Senior Associate
Aboretum Ventures

Sarah joined Arboretum in 2020 and is responsible for assessing potential investments and supporting Arboretum’s portfolio companies. Prior to joining Arboretum, Sarah spent eight years providing clinical and technical support for cardiac medical device procedures, sales, and clinical trials at Johnson & Johnson, Sorin, and, most recently, Boston Scientific.

 

Sarah earned an MSE in Biomedical Engineering and a BS in Cellular and Molecular Biology from the University of Michigan and an MBA from the Ross School of Business at the University of Michigan.

 

Cheryl Kerr

Executive Director US Women's Healthcare Marketing
Bayer

Cheryl Kerr

Executive Director US Women's Healthcare Marketing
Bayer

Cheryl Kerr

Executive Director US Women's Healthcare Marketing
Bayer
 

Vinita Kailasanath

Partner, Life Sciences and Tech Transactions
Freshfields

Vinita Kailasanath

Partner, Life Sciences and Tech Transactions
Freshfields

Vinita Kailasanath

Partner, Life Sciences and Tech Transactions
Freshfields
 

Georgie Kovaks

Founder
Fempower Health

Georgie Kovaks

Founder
Fempower Health

Georgie Kovaks

Founder
Fempower Health
 

Gina Nebesar

Chief Product Officer and Co-Founder
Ovia Health

Gina Nebesar is the co-founder of Ovia Health, the leading digital health platform for families, offering evidence-based, daily support across the full spectrum of family care - from family building and fertility to prenatal health and parental wellbeing. As the Chief Product Officer, she scaled the platform to over 15 million people globally and brought equitable access to communities through over 2,000 partnerships with health plans, employers, and channel relationships.

Gina Nebesar

Chief Product Officer and Co-Founder
Ovia Health

Gina Nebesar

Chief Product Officer and Co-Founder
Ovia Health

Gina Nebesar is the co-founder of Ovia Health, the leading digital health platform for families, offering evidence-based, daily support across the full spectrum of family care - from family building and fertility to prenatal health and parental wellbeing. As the Chief Product Officer, she scaled the platform to over 15 million people globally and brought equitable access to communities through over 2,000 partnerships with health plans, employers, and channel relationships. Gina is also an Ovia mom of three kids and women’s health ambassador with over 50 million views of her Ovia Pregnancy video series chronicling her journey to motherhood. She is passionate about using digital health to break down barriers to self-advocacy and preventative care.

Prior to Ovia Health, Gina founded Automatic Apparel, a high tech vending machine company for electronics and apparel - featured in the Boston Herald, Martha Stewart Show, CNN, and USA Today.
Gina began her career in engineering and manufacturing at Northrop Grumman Aerospace Systems, supervising assembly line production of spaceflight hardware.


Gina earned a B.S. in Industrial and Systems Engineering at the University of Southern California, and an MBA from Harvard Business School

Download 2022 agenda

Please complete the form to access the 2022 Women's Health Innovation Summit (WHIS) Agenda.

The 2022 agenda includes:

- Plenary sessions: consider the challenges and topics that span the Women’s Health Industry, including health equity, and menopause.
- Business Development: a track designed for start-up growth, understanding funding models and investment strategies.
- R&D: explore topics that address challenges within data privacy, lab innovation and diversity in clinical trials.

View our agenda for the Women's Health Innovation Summit 2022

REGISTRATION

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:

Registration ends in

Saturday, August 27, 2022 to Friday, September 30, 2022
Emerging - $10mil rev and under
$1,299
Standard
Start-Ups/Emerging Organisations
FemTech
MenoTech
Accelerators
Saturday, August 27, 2022 to Friday, September 30, 2022
Industry
$1,999
Standard
Pharmaceutical
Medical Device
Biotechnology
Investors
Payors/Insurers
Employers
Friday, August 26, 2022 to Friday, September 30, 2022
Service Providers
$2,599
Standard
Consultancies
Financial Advisors
Lawyers
CRO's
Laboratories
Tuesday, March 8, 2022 to Friday, September 30, 2022
Academic/NPO/Charity
$499
SOLD OUT -Please contact [email protected] to enquire about tickets
Academic
Not-for-profit Organisations
Charities
Advocacy Groups
Government Bodies
Health Care Professionals
Preparing registration...

Interested in sponsoring?

Please email [email protected] for all sponsorship and exhibition enquiries.

AUDIENCE BREAKDOWN

Big Pharma and Medical Device

At the forefront of women’s health innovation, Big Pharma and Medical Device companies play an important role at the Women’s Health Innovation Summit.

Startups

At the centre of our summit, we are committed to bringing together emerging
companies in women’s health, at all stages of growth and development who are
looking for partnership opportunities and are at the forefront of shaping the future of women’s health in this ever-changing landscape.

Investors

We look to bring together leading women’s health investors, alongside those
with an interest or focus on specific areas within women’s health. Investors
range from seed, to angel, venture capital firms, private equity, funds, and
advisors.

Servicing

Industry support and service providers include advocacy groups, researchers, knowledge leaders and accelerators such as consultants, lawyers, CROs, non-profits and regulatory experts.

Employers

This year, we’re looking expand the scope of stakeholders and hear more from employers, who play an important role in the women’s care across the world.

Payers/Insurers

Payers and insurance companies provide an important bridge between stakeholders within the women’s health industry, and we are delighted to have more joining us at this years’ summit.

FMCGs

Fast moving consumer goods companies play an important role in the women’s health landscape and include companies such as J&J, P&G.

Partner With Us

Based on your objectives, we can create bespoke packages designed specifically for you – from presenting your expertise on the main stage, to hosting a private dinner. You can partner with us showcase your brand and make valuable new connections. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding & Networking.

To discuss your objectives and partnership opportunities please contact [email protected]

Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact [email protected]

Venue Description

Venue

The Westin Copley Place, Boston, 10 Huntington Avenue, Boston, MA, 02116

Step into a AAA Four-Diamond hotel in downtown Boston's celebrated Back Bay area - a short stroll from fine dining destinations and upscale clothing stores in the popular Copley Place shopping mall. The Westin Copley Place, Boston welcomes guests with modern hotel accommodations and signature touches.

Boston Symphony Hall, Fenway Park and other downtown attractions are within easy reach of our hotel. In the evening, retreat to beautifully appointed hotel rooms and suites featuring stylish decor, the plush Westin Heavenly® Bed and spacious bathrooms.

Book your room! 

For recommended hotels in the area, please use this link: https://HotelMap.com/MXBAU

 

 

 

Returning Safely Measures

Whether sponsors, speakers or attendees, our customers attend Kisaco Research events to connect, learn and innovate to know more and do business. It is our commitment that as we return to in-person events, they can do this effectively, safely and with confidence.

All in-person Kisaco Research events will prioritize the health and safety of colleagues and customers and, in the first instance, will be run in accordance with official government and local authority guidance, as well as any venue or location-specific regulations.

Kisaco Research is committed to following the Association of Event Organisers All Secure Standard, which has been approved by by UK Government.

Download the Kisaco Research Returning Safely Measures 

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us

Other events you might be interested in:

Women's Health Innovation Series: Women's Healthy Aging Summit

Women's Health Innovation Summit, Europe

Reproductive Health Innovation Summit